Influence of smoking status on the disease-related outcomes of patients with tobacco-associated superficial transitional cell carcinoma of the bladder

Cancer

Volumn 86, Issue 11, 1999, Pages 2337-2345

  Fleshner, Neil ^a   Garland, JoAnne ^b   Moadel, Alyson ^c   Herr, Harry ^b   Ostroff, Jaimie ^b   Trambert, Rene ^b   O'Sullivan, Maryellen ^b   Russo, Paul ^b  

^a DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Bladder carcinoma; Disease recurrence; Epidemiology; Risk factors; Smoking

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER REGISTRY; CANCER SURVIVAL; CIGARETTE SMOKING; CONTROLLED STUDY; DISEASE ASSOCIATION; EXPOSURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; QUESTIONNAIRE; SMOKING CESSATION; SUPERFICIAL CANCER; TOBACCO; TRANSITIONAL CELL CARCINOMA;

ADULT; AGED; CARCINOMA, TRANSITIONAL CELL; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OUTCOME ASSESSMENT (HEALTH CARE); SMOKING; SMOKING CESSATION; SURVIVAL ANALYSIS; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 0033429879     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19991201)86:11<2337::AID-CNCR23>3.0.CO;2-6     Document Type: Article

References (43)

1. Parker SL, Tong T, Bolden S , Wingo PA. Cancer statistics, 1997. CA Cancer J Clin 1995;47:5-27.
2. Burch JD, Rohan TE, Howe GR, Risch HA, Hill GB, Steele R, et al. Risk of bladder cancer by source and type of tobacco exposure: a case-control study. Int J Cancer 1989;44:622-8.
3. Catalona W. Urothelial tumors of the urinary tract. In: Walsh PC, Retik AB, Stamey TA, Vaughan ED. editors. Campbell's urology. 6th edition. Philadelphia: W. B. Saunders, 1992: 1094-1194.
4. Pederson-Bjergaard J, Ersboll J, Hansen VL, Sorensen BL, Christoffersen K, Hou-Jensen K, et al. Carcinoma of the urinary bladder after treatment with cyclophosphamide for non-Hodgkin's lymphoma. N Engl J Med 1988;318:1028-32.
5. Quilty PM, Ken GR. Bladder cancer following low or high dose pelvic radiation. Clin Radiol 1987;38:583-86.
6. Scher HI. High-risk papillomavirus infections and overexpression of p53 protein as prognostic indicators in transitional cell carcinoma of the urinary bladder. J Urol 1994;152: 568-69.
7. Fleshner N, Hen H, Stewart A, Murphy GP, Mettlin C, Menck HR. The National Cancer Data Base report on bladder carcinoma. Cancer 1996;78:1505-13.
8. Lamm DL, Blumenstein BA, Crawford ED, Montie JE, Scardino P, Grossman HB, et al. A randomized trial of intravesical doxorubicin and immunotherapy with bacille Camette-Guérin for transitional carcinoma of the bladder. N Engl J Med 1991;325:1205-9.
9. Rintala E, Jauhiainen K, Kaasinen E, Nurmi M, Alfthan O. Alternating mitomycin C and bacillus Calmette-Guérin instillation prophylaxis for recurrent papillary superficial bladder cancer. J Urol 1996;156:56-60.
10. Martinez-Pineiro LA, Leon JJ, Martinez-Pineiro L Jr., Fiter L, Mosteiro JA, Navarro J, et al. Bacillus Calmette-Guérin versus doxorubicin versus thiotepa: a randomized study in 202 patients with superficial bladder cancer. J Urol 1990;143: 502-6.
11. Herr HW, Laudone VP, Badalament RA, Oettgen HF, Sogani PC, Freedman BD, et al. Bacillus Calmette-Guérin therapy alters the progression of superficial bladder cancer. J Clin Oncol 1988;6:1450-5.
12. Zippe C, Pandrangi L, Agarwal A. NMP22 is a sensitive, cost-effective test in patients at risk for bladder cancer. J Urol 1999;161:62-5.
13. Russo P, Fleshner NE, Garland J, Moadel A, Herr H, Fair WR. Prevalence and patterns of tobacco use in patients with superficial bladder cancer. J Urol 1996;136;1521A.
14. Silverman S, Gorsky M, Greenspan D. Tobacco usage in patients with head and neck carcinomas: a follow-up study on habit change and second primary oral/oropharyngeal cancers. J Am Dental Assoc 1983;106: 33-5.
15. Richardson GE, Tucker MA, Venzon DJ, Linnoila RI, Phelps R, Phares JC, et al. Smoking cessation after successful treatment of small-cell lung cancer is associated with fewer smoking-related second primary cancers. Ann Intern Med 1993;119:383-90.
16. Zhang ZF, Sarkis AS, Cardo CC, Dalbagni G, Melamed J, Aprikian A, et al. Tobacco smoking, occupation, and p53 nuclear overexpression in early stage bladder cancer. Cancer Epidemiol Biomarkers Prev 1994;3:19-4.
17. Spruck CH, Rideout WM, Olumi AF, Ohneseit PF, Yang AS, Tsai YC, et al. Distinct pattern of p53 mutations in bladder cancer: relationship to tobacco use. Cancer Res 1993;53: 1162-6.
18. Esrig D, Elmajian D, Groshen S, Freeman JA, Stein JP, Chen SC, et al. Accumulation of nuclear p53 and tumor progression in bladder cancer. N Engl J Med 1994;331:1259-64.
19. Ross RK, Jones PA, Yu MC. Bladder cancer epidemiology and pathogenesis. Semin Oncol 1996;23:536-45.
20. Hoffmann D, Hecht SS. Advances in tobacco carcinogenesis. In: Cooper CS, Grover PL. Chemical carcinogenesis and mutagenesis. Berlin: Springer-Verlag, 1990:136-52.
21. Barisch H, Malaveille C, Friesen M, Kadlubar FF, Vineis P. Black (air-cured) and blond (flue-cured) tobacco cancer risk. IV: Molecular dosimetry studies implicate aromatic amines as bladder carcinogens. Eur J Cancer 1993;29;1199-1207.
22. Carpenter AA. Clinical experience with transitional cell carcinoma of the bladder with special reference to smoking. J Urol 1989;141:527-8.
23. Thompson IM, Peek M, Rodriguez FR. The impact of cigarette smoking on stage, grade and number of recurrences of transitional cell carcinoma of the bladder. J Urol 1987;137: 401-3.
24. Sturgeon SR, Hartge P, Silverman DT, Kantor AF, Linehan WM, Lynch C, et al. Associations between bladder cancer risk factors and tumor stage and grade at diagnosis. Epidemiology 1994;5:218-25.
25. Hayes RB, Freidell GH, Zahm SH, Cole P. Are the known bladder cancer risk factors associated with more advanced bladder cancer? Cancer Causes Control 1993;4:157-62.
26. Koch M, Hill GB, McPhee MS. Factors affecting recurrence rates in superficial bladder cancer. J Natl Cancer Inst 1986; 76:1025-9.
27. Michalek AM, Cummings KM, Pontes JE. Cigarette smoking, tumor recurrence and survival from bladder cancer. Prev Med 1985;14:92-8.
28. Raitenen MP, Niemenen P, Tammela TL. Impact of tumor grade, stage, number and size, and smoking and sex, on survival in patients with transitional cell carcinoma of the bladder. Br J Urol 1995;76:470-4.
29. Ostroff JS, Jacobsen PB, Moadel AM, Spiro RH, Shah JP, Strong EW, et al. Prevalence and predictors of continued tobacco use after treatment of patients with head and neck cancer. Cancer 1995;75:569-76.
30. Esrig D, Freeman JA, Elmajian DA, Stein JP, Chen SC, Groshen S, et al: Transitional cell carcinoma involving the prostate with a proposed staging classification for stromal invasion. J Urol 1996;156:1071-6.
31. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
32. Peto R, Peto J. Asymptotically efficient rank invariant procedures. J R Stat Soc 1972;153:185-207.
33. Gehan EA. A generalized Wilcoxon test for comparing arbitrarily singly censored samples. Biometrika 1965;b:650-3.
34. Cox DR. Regression models and life tables. J R Stat Soc 1972;34:187-220.
35. Fleiss J. Statistical methods for rates and proportions. 2nd edition. New York: John Wiley & Sons, Inc., 1981.
36. Fitzpatrick JM, West AB, Butler MR, Lane V, O'Flynn JD. Superficial bladder tumors: the importance of recurrence pattern following initial resection. J Urol 1986;135:920-2.
37. Hudson MA, Humphrey PA, Swanson PE. Gender affects interval to early recurrence in bladder cancer patients (abstract). J Urol 1997;157: 116.
38. Friedman LM, Furberg CD, DeMets DL. Fundamentals of clinical trials. 3rd edition. New York: Mosby, 1996.
39. Pojer R, Whitfield JB, Poulos V, Eckhard IF, Richmond R, Hensley WJ. Carboxyhemogobin, cotinine and thiocyanate assay compared for distinguishing smokers from nonsmokers. Clin Chem 1984;30:1377-80.
40. Bradford Hill A. Principles of medical statistics. 9th edition. New York: Oxford University Press, 1971.
41. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994; 264:436-40.
42. Giralt M, Lafuente A, Pujol F, Mallol J. Enhanced glutathione S-tranferase activity and glutathione content in human bladder cancer. Follow-up study: influence of smoking. J Urol 1993;149:1452-4.
43. Chinegwundoh FI, Kaisary AV. Polymorphism and smoking in bladder carcinogenesis. Br J Urol 1996;77:672-5.